Canakinumab shows superior efficacy and safety over anakinra in male patients with VEXAS syndrome, a multicenter study finds.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/canakinumab-better-than-anakinra-treating-vexas-syndrome-2025a1000r02?src=rss
Author :
Publish date : 2025-10-07 21:06:00
Copyright for syndicated content belongs to the linked Source.